Germline HLA heterozygosity is associated with decreased lung cancer risk

Tan T, Shaw VR, Byun J, Lee HS, Han Y, Li Y, Hung RJ, Christiani DC, Wang XA, Johansson M, Xiao X, Zaridze D, Bojesen SE, Shete S, Albanes D, Aldrich MC, Tardon A, Fernandez-Tardon G, Le Marchand L, Rennert G, Bickeböller H, Wichmann HE, Risch A, Field JK, Davies M, Woll P, Kiemeney LA, Haugen A, Zienolddiny S, Lam S, Johansson M, Grankvist K, Schabath MB, Andrew A, Lazarus P, Arnold SM, Zhu D, Landi MT, McKay J, Amos C, Cheng C.
HGG Adv. 2026 Jan 12:100567. doi: 10.1016/j.xhgg.2026.100567
Article
Jan 14, 2026
Consortium publication
No